¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13
±³À°ÀÏÀÚ : 2020-08-13
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1      
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : kasl@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã 
±³À°½Ã°£ : 11 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Member-KRW 50,000/Resident, Trainee, Nurse, Army Doctor, Others-KRW 30,000Non-Member, Healthcare Professional-KRW 60,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:20 Pharmacological Treatment of Alcoholic Hepatitis  Gyongyi Szabo(Harvard Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:20~09:40 Pharmacological Treatment of Nonalcoholic Steatohepatitis  Manal Abdelmalek(Duke Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:40~10:00 New Horizon of Immuno-Oncologic Therapy  Amit Singal(Univ. of Texas Southwestern USA) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:10 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:05~09:25 Obesity and Alcohol Are Deadly Combination to Induce Steatohepatitis  Bin Gao(National Institutes of Health USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:25~09:45 Alcohol-NAFLD Interactions  Kenichi Ikejima(Juntendo Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:45~10:05 Autophagy Regulation in Alcoholic and Non-Alcoholic Liver Steatosis  Sang Geon Kim(Seoul National Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:05~10:25 Alcohol-NAFLD Interactions in a Large Korean Cohort Study  Yong Kyun Cho(Sungkyunkwan Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:25~10:35 Interaction between CD40L and CD40 Mediates Hepatic Exosomal Delivery to Kupffer Cells in Alcoholic Liver Disease  Kyurae Kim(KAIST) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:35~10:45 The Effect of Intestinal Flora Modification on Alcoholic Liver Injury in Obese KK-Ay Mice  Kazuyoshi Kon(Juntendo Univ. Japan) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:45~11:00 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:20~11:20 Plenary Presentation 1  Kwan Sik Lee Kwan Soo Byun Ho Seong Han(Yonsei Univ Korea Univ Seoul National Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:00~11:20 Neuroendocrine-Fat-Liver Axis  Laura E. Nagy(Cleveland Clinic USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:20~11:40 Lymphatic System and Organ Crosstalk  Yasuko Iwakiri(Yale Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:40~12:00 Liver-Lung Crosstalk  Gavin E. Arteel(Univ. of Pittsburgh USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:00~12:20 Glutamate/mGluR5-mediated Endocannabinoid in Alcoholic Fatty Liver  Won-IL Jeong(KAIST) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:20~12:30 CYP2E1 Regulation of Ethanol-Induced Intestinal miRNAs in Liver Injury  Je-Hyun Yoon(Medical Univ. of South Carolina USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:30~12:40 Chronic Alcohol Consumption Alters the Phenotype of F4/80+CD11b+ Bone Marrow Cells by Neuro-Metabolic Signaling Pathway  Young-Ri Shim(KAIST) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:40~13:00 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:30~12:00 Past, Present, and Future of Precision Hepatology: Where Do We Need to Go?  W. Ray Kim(Stanford Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Current Evidences and Future Perspectives for the Treatment of Advanced Hepatocellular Carcinoma  Jeong Won Jang(The Catholic Univ. of Korea) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 When Should We Consider Systemic Therapy in BCLC Stage B Hepatocellular Carcinoma?  Hyung Joon Yim(Korea Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Therapeutic Efficacy of Transarterial-Based Treatment vs. Targeted Therapy in Advanced Hepatocellular Carcinoma  Sadahisa Ogasawara(Chiba Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:00~14:20 Optimizing Therapeutic Efficacy with Systemic Treatment and Radiotherapy in Hepatocellular Carcinoma  Jinsil Seong(Yonsei Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:20~14:30 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:50~14:40 General Oral Presentation 1 (*K)  Byung Ik Kim(Sungkyunkwan Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:40~14:55 Current Approaches to the Treatment of Early HCC in Japan  Naoshi Nishida(Kindai Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:55~15:10 Current Approaches to the Treatment of Early HCC in Korea  Myeong Jun Song(The Catholic Univ. of Korea) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:10~15:25 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Japanese Experience  Do Young Kim(Yonsei Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:25~15:40 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Korean Experience  Hee Chul Park(Sungkyunkwan Univ) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:40~15:50 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:00~16:20 Exploring Unrecognized Risks in Immune Tolerant Phase of Chronic Hepatitis B  Young-Suk Lim(Univ. of Ulsan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:20~16:40 Clonal Hepatocyte Expansion and Hepatitis B Virus Integration  Patrick Kennedy(Queen Mary Univ. of London UK) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:40~17:00 Effect of Current and Novel Antivirals on the Prevention of Hepatocellular Carcinoma: Beyond Viral Suppression  George V. Papatheodoridis(National and Kapodistrian Univ. of Athens Greece) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:00~17:20 Functional Cure of Chronic Hepatitis B and Beyond  Man-Fung Yuen(The Univ. of Hong Kong Hong Kong) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:20~17:30 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¹°¡»ý¸íÀ±¸®Á¤Ã¥¿ø Á¦5Â÷ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»¡¤½ÉÈ­±³À° : 2020-08-14
´ÙÀ½±Û ´ëÇÑ°³¿ø³»°úÀÇ»çȸ 2020³â Á¦2ȸ ÃÊÀ½Æı³À° : 2020-08-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20919 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 42 2024-05-28
20918 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 92 2024-05-28
20917 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 33 2024-05-28
20916 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 48 2024-05-28
20915 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 42 2024-05-28
20914 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 52 2024-05-28
20913 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 55 2024-05-28
20912 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 40 2024-05-28
20911 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 41 2024-05-28
20910 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 47 2024-05-28
20909 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 49 2024-05-28
20908 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 25 2024-05-28
20907 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 29 2024-05-28
20906 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20905 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 17 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷